Introduction
============

Bacterial extracellular polysaccharides (EPS) presenting a wide range of physicochemical properties have emerged as promising polymers for many commercial applications in different industrial sectors like food, pharmaceuticals, cosmetics, oil drilling, and paper manufacturing ([@B26]; [@B19]). Despite this potential, bacterial EPS currently represent a very small fraction of the global polymer market, mostly because of their production costs. However, in some cases, they might address very specific niche markets, where the production cost does not become a limiting step for their commercialization ([@B19]).

Rare sugars are monosaccharides that are not commonly found in nature, where [D]{.smallcaps}-glucose, [D]{.smallcaps}-galactose, [D]{.smallcaps}-fructose, [D]{.smallcaps}-xylose, [D]{.smallcaps}-ribose, and [L]{.smallcaps}-arabinose are more abundant. Rare sugars such as [L]{.smallcaps}-fucose, [L]{.smallcaps}-rhamnose, or uronic acids present many interesting properties, making them attractive for various fields of applications, such as anti-inflammatory substances, antioxidant, or as building blocks to synthesize the nucleoside analogs which are used as antiviral agents, and justifying the effort to produce them synthetically ([@B27]). Today, some of them might be produced biochemically by the use of specialized enzymes belonging usually to the classes of keto--aldol isomerases, epimerases, and oxidoreductases using glucose as main precursor ([@B22]; [@B6]). Their scarceness makes them highly valuable and, consequently, bacterial EPS containing rare sugars represent an interesting source for their isolation and production. Although polysaccharides containing rare sugars are also found in plants, seaweeds, and animals, microbial production of such polymers is advantageous for several reasons, namely, production is not affected by environmental factors, the bioprocesses are easily controlled and manipulated, and they guaranty fast and reproducible production.

Some EPS containing rare sugars have been extensively studied (Table [1](#T1){ref-type="table"}), not only because of their composition, but also because of their physical and bioactive properties. These include polymers containing fucose, such as colanic acid ([@B43]), fucogel ([@B37]), clavan ([@B56]), or FucoPol ([@B20]), or rhamnose, such as rhamsan ([@B60]), gellan ([@B62]), or welan gum ([@B57]; Figure [1](#F1){ref-type="fig"}).

###### 

**Production and composition details of some bacterial polysaccharides rich in rare sugars**.

  **EPS**           **Producing strain**          **Composition**                                   **Substrates**   **Production (g/L)**   **Productivity (g/L·day)**   **Reference**
  ----------------- ----------------------------- ------------------------------------------------- ---------------- ---------------------- ---------------------------- ---------------
  Gellan gum        *Sphingomonas paucimobilis*   Rhamnose, glucose, and glucuronic acid            Sucrose          19.9--22.6             6.6--9.0                     [@B62]
                                                                                                    Glucose          12.4                   7.4                          [@B21]
                                                                                                    Whey             1.6--3.1               0.6--1.2                     [@B12]
                                                  Acetyl and glyceryl groups                        Soluble starch   37.5--43.6             14.5--18.8                   [@B3]
                                                                                                    Molasses         13.8                   n.a.                         [@B4]
  Welan             *Alcaligenes* sp.             Rhamnose, glucose, and glucuronic acid            Glucose          25.0--26.3             8.3--8.8                     [@B28]
                                                                                                    Corn starch      22.8                   7.6                          [@B29]
  Clavan            *Clavibacter michiganensis*   Fucose, glucose, and galactose                    Glucose          0.7                    0.06                         [@B55]
                                                  Acetyl, pyruvyl, and succinyl groups                                                                                   
  FucoPol           *Enterobacter* A47            Fucose, glucose, galactose, and glucuronic acid   Glycerol         7.5--8.0               2.0--2.5                     [@B54]
                                                                                                    Glucose          13.4                   3.4                          [@B18]
                                                                                                    Xylose           5.4                    1.4                          [@B18]
                                                  Acetyl, pyruvyl, and succinyl groups                                                                                   
  Hyaluronic acid   *Streptococcus* sp.           Glucuronic acid and acetylglucosamine             Glucose          0.4--6.9               0.8--1.5                     [@B23]

![**Schematic diagram of the biosynthetic pathways in Gram-negative bacteria involved in the intracellular synthesis of nucleoside diphosphate sugars that are precursors of some rare sugar monomers (Fuc, fucose; Glc, glucose; GlcA, glucuronic acid; Man, mannose; Rha, rhamnose; Fru, fructose; GDP, guanosine diphosphate; TDP, tyrosine diphosphate; UDP, uridine diphosphate)**.](fmicb-06-00288-g0001){#F1}

Extensive work has been performed to discover new strains able to produce such rare sugar-rich EPS and to improve their production and purification processes. Many of those polymers are being studied for new applications in pharmaceuticals cosmetics, food products, among others. Rare sugar-rich EPS can also be used as sources of rare sugar monosaccharides. Such EPS can be subjected to hydrolysis (either enzymatic or chemical) and the resulting monomers can be separated by chromatographic methods to yield pure monosaccharides. The rare sugars thus obtained can then be used as precursors for the synthesis of high-value molecules for use in high-value applications. The exploitation of EPS as sources of rare sugars still remains a rather unexplored and unexploited aspect. The economic viability of such strategy depends on the EPS content on a given rare sugar but the high demand for these molecules will be a strong driving force.

EPS Containing Rare Sugars and Their Producers
==============================================

Even though not all rare sugars can be found in microbial polysaccharides, some EPS, secreted by bacteria in specific limited conditions, contain rare sugars, offering an opportunity to produce them in sustainable and controlled conditions. These include polymers containing fucose, such as colanic acid, fucogel, and clavan, or rhamnose, such as rhamsan, gellan, diutan, or welan gum, very often in combination with uronic acids such as glucuronic or galacturonic acids ([@B26]).

Similarly to most bacterial EPS, rare sugar enriched EPS synthesis occurs intracellularly ([@B19],[@B20]). Energy-rich monosaccharides, mainly nucleoside diphosphate sugars (NDP-sugars), are synthesized from phosphorylated sugars formed from primary metabolites (Figure [1](#F1){ref-type="fig"}). Polymerization commonly occurs at the cytoplasmic face of the inner membrane or at the periplasm, and the polysaccharides are exported to the extracellular.

The presence of rare sugars on bacterial EPS is not well understood yet, but they may provide the cells with an extra biological protection in addition to the physical barrier provided by the EPS.

Rhamnose Containing EPS
-----------------------

Most rhamnose containing EPS belong to the family of sphingans are secreted by strains of the *Sphingomonas* genus ([@B16]). Sphingans, as rhamsan, gellan, diutan, or welan gum present a common linear tetrasaccharide repeating unit Glc-GlcA-Glc-Rha or Man ([@B41]). The presence of rhamnose or mannose at the end the repeating unit is responsible for the main structural variations between sphingans. For instance, diutan has exactly the same backbone as gellan (Glu-GlcA-Glu-Rha) but is substituted with Rha-Rha side chain. *Klebsiella* genus also presents EPS producers. For instance, *Klebsiella* I-714 produces an EPS with a high rhamnose content, composed of hexasaccharide units of [L]{.smallcaps}-rhamnose, [D]{.smallcaps}-galactose, and [D]{.smallcaps}-glucuronic acid in a molar ratio of 3:2:1 ([@B47]).

Fucose Containing EPS
---------------------

Clavan, composed of tetrasaccharide repeating units of [D]{.smallcaps}-glucose, [D]{.smallcaps}-galactose, [L]{.smallcaps}-fucose, and pyruvic acid in the molar ratio of 1:1:2:1, is one of the richest polymers in fucose. It is produced by *Clavibacter* strains, in particular *C. michiganensis* ([@B56]). In comparison, Fucogel, commercialized by Solabia (France) is a linear anionic polymer produced by *K. pneumoniae*, constituted of trisaccharide repeating units of galacturonic acid, [L]{.smallcaps}-fucose, and [D]{.smallcaps}-galactose ([@B56]). A marine bacterium *Enterobacter cloacae* was also reported to produce a polymer composed fucose, galactose, glucose, and glucuronic acid in a molar ratio of 2:1:1:1 ([@B24]). The strain *Enterobacter* A47 synthesizes FucoPol, a fucose-containing polysaccharide with nearly equimolar amounts of fucose, glucose, and galactose, and minor content of glucuronic acid (10--15 mol%; [@B20]).

Other Bacterial EPS
-------------------

Even rarer sugars that rhamnose and fucose might be encountered in bacterial EPS. For instance, strains of the rumen bacterium *Butyrivibrio fibrisolvens* produce significant amounts of EPS containing [L]{.smallcaps}-altrose and [L]{.smallcaps}-iduronic acid ([@B15]). Due to its scarcity, reports on altrose production and applications remain still limited today. *Pseudomonas viscogena* produces a polysaccharide containing another scarce sugar, allose, the C2 epimer of altrose, but only in small proportion (around 2.5% of sugar content; [@B50]). A much more studied rare sugar containing EPS is hyaluronic acid (HA), because of its proven properties ([@B10]). HA is a linear polymer composed of *N*-acetylglucosamine and glucuronic acid, as disaccharidic repeating units produced by *Streptococcus zooepidemicus* ([@B30])

Bioproduction
=============

Cultivation Conditions
----------------------

Bacterial EPS are industrially produced in single strain systems ([@B26]). As for other bacterial EPS production bioprocesses, the production of EPS rich in rare sugars rely on the use of carbohydrates as carbon sources because they allow for high productivities and yields (Table [1](#T1){ref-type="table"}; [@B27]). Sucrose and glucose are the most commonly used substrates, while xylose, galactose and lactose are less frequently used because many bacteria are unable to use them or they result in reduced polymer productivities ([@B48]; [@B61]). Since the substrate cost accounts for up to 40% of the total production costs of microbial polymers ([@B26]), there is an intensive search for alternative raw materials to reduce the overall production costs. For that reason, several inexpensive agricultural and industrial wastes and by-products have been proposed as substrates for microbial cultivation, including lignocellulosic materials, cheese whey, molasses, and glycerol-rich product (Table [1](#T1){ref-type="table"}). On the other hand, the use of some agricultural and industrial wastes/by-products is held up by the difficulty in guarantying their supply in terms of both quantity and quality, and they may require costly pretreatments prior to use. Moreover, non-reacted components may accumulate in the broth and eventually be carried-over to the final product. Hence, for applications wherein high-purity and high quality products are needed, the use of wastes or by-products may not be an option or, otherwise, higher investment must be put in downstream procedures ([@B19]).

Media composition and cultivation conditions highly influence the amount of polysaccharide synthesized, as well as the final product's composition, molecular structure, average molecular weight, and, consequently, their functional properties ([@B34]; [@B40]). Hence, it is possible to manipulate polysaccharides' characteristics by altering the growth conditions of the producing strains, thus obtaining biopolymers with tailored properties to fit a given application. Enrichment of the polysaccharides in rare sugar monomers is of particular interest since it may enhance their bioactive properties, thus increasing their market value. However, the impact of media and cultivation conditions on EPS composition is strain-dependent and only a few bacteria can be manipulated to alter the composition of the EPS they synthesize. In fact, for most bacteria, EPS sugar composition is a genetically determined trait, which is not significantly altered by the cultivation conditions ([@B31]; [@B8]). An exception to this is, for example, the bacterium *Enterobacter* A47 that was shown to be able to synthesize EPS with different fucose contents by cultivation as a function of the carbon source used and the operating conditions ([@B54]; [@B18]). High fucose content EPS (36--38 mol%) were synthesized by *Enterobacter* A47 using glycerol or xylose as sole carbon sources, while glucose, methanol or citrate led to lower contents (22--29 mol%; [@B18]). On the other hand, the composition of the EPS produced by *Enterobacter* A47 could also be manipulated by cultivation at different pH and/or temperature ranges: maximum fucose content (\>30 mol%) was obtained for cultivation at 25--35°C and pH = 6.0--8.0 ([@B54]).

Downstream Processing
---------------------

The recovery of bacterial EPS from the culture broth commonly involves cell removal, usually by centrifugation or filtration, polymer precipitation from the cell-free supernatant by the addition of a precipitating agent consisting of a water-miscible solvent in which the polymer is insoluble (e.g., methanol, ethanol, isopropanol, acetone) and drying of the precipitated polymer (e.g., by freeze drying, drum drying; [@B19], [@B17]). For some applications that require high purity grade products, the polymer is subjected to one or several additional methods, such as re-precipitation of the polymer from diluted aqueous solution, deproteinization by chemical or enzymatic methods, and membrane processes, such as dialysis, ultrafiltration and diafiltration ([@B27]; [@B58]; [@B1]; [@B2]; [@B19]). The most appropriate downstream procedure is selected to guaranty the required products' purity. Additionally, the impact of the purification procedures on the polysaccharides' properties must also be taken in consideration.

Industrial and Biomedical Applications
======================================

Most polysaccharides' applications are related to their behavior in aqueous media. Their physical and chemical characteristics, such as water binding capacity, high average molecular weight, polyelectrolyte behavior (in some cases), molecular structure, and the possibility of being chemically modified, enables this type of molecules to present diverse functional properties (e.g., thickening, film forming, gelling, emulsion stabilizing, flocculating, and nano/microstructures production abilities; [@B13]). Furthermore, in the case fucose and rhamnose-rich bacterial polysaccharides, they also present interesting biological activities that render these molecules potential to be used in a wide range of applications, particularly in added value products like cosmetics, pharmaceuticals, medical devices, and functional food products ([@B38]; [@B44]). As examples, rhamnose is commonly used as precursor for the production of aroma and flavors and, together with fucose, has attracted more attraction as fucose and rhamnose-rich oligo- and polysaccharides (FROP and RROP, respectively) have been found to counteract several of the mechanisms involved in skin aging ([@B45]).

Gellan gum is a linear anionic EPS, and its native form contains two acyl substituents, [L]{.smallcaps}-glyceryl and acetyl, being known as high acyl gellan (HA-gellan). The substituents may be removed by alkaline hydrolysis to give deacetylated gellan, also called low acyl gellan (LA-gellan). HA-gellan usually produces elastic, soft, non-brittle, and opaque gels while LA-gellan enables the formation of non-elastic, hard, brittle, and transparent gels ([@B49]). Therefore, a wide range of structures, with varied rheological properties and appealing textures may be designed by controlling the acyl content. Gellan produced by cultivation of a pure culture of *Sphingomonas elodea* using a sugar as carbon source, and commercialized by CPKelco (with the trade name KELCOGEL^®^), has been used in the food industry as additive that functions, not only as gelling, but also as texturizing, stabilizing, suspending, film-forming, and structuring agent. Types of food products that contain gellan gum include bakery fillings, dairy products, low-fat spreads, dessert gels, jams and jellies, sauces, and structured foods ([@B17]; [@B42]). It has also been used to develop edible coatings for the improvement of fruits shelf life ([@B46]; [@B52]).

The applications of gellan gum in pharmaceutical technology and medicine were recently reviewed by [@B36]. In pharmaceuticals, it has been studied as carrier material in drug delivery, in the form of tablets, capsules, beads, and hydrogels. Formulations based on gellan gum for oral, ophthalmic, and nasal applications have been developed. In medicine field, the use of gellan has been investigated for tissue engineering (e.g., for cartilage reconstruction and guided bone regeneration) and wound healing (e.g., in wound dressings to inhibit postsurgical adhesion and scar formation). Gellan sulfate derivatives are promising materials for rheumatoid arthritis treatment, as they have a tendency for selective binding of fibronectin molecules ([@B32]), and for the development of cell-hybrid materials for artificial veins design due to the anticoagulant activity of such derivatives ([@B33]).

Regarding welan gum, the main applications studied so far are in the field of cement production. The use of low viscosity welan gum in cement compositions reduces fluid loss of those compositions, increases the suspension properties of cement suspensions, being effective at low concentrations ([@B25]). The rheological properties of welan gum in aqueous media were compared to that of xanthan gum, well known for its good thickening capacity. For the same biopolymer concentration, welan solutions presented higher apparent viscosity and higher viscoelastic moduli (loss and storage moduli). In addition, the welan gum solution is able to maintain high viscosity at high temperature while the molecular aggregation of xanthan gum is more sensitive to temperature variations ([@B59]). As such, it is envisaged the application of welan gum in the same areas as xanthan gum, such as in food products (e.g., jellies, beverages, dairy products, and salad dressings); as well as in oil drilling fluids. As welan gum is a rhamnose containing polysaccharide, attention should be driven to the study of its biological activity and applications in the cosmetic, pharmaceutical, and medicine fields.

Native rhamsan gum is non-gel forming polysaccharide, but originates thermostable highly viscous solutions even at temperatures above 100°C. It possesses good stability under shearing, great compatibility with high salt concentrations and excellent suspension properties, even superior to that of xanthan gum. Furthermore, gelation was observed in deacetylated rhamsan gum solution at concentrations of 0.3%wt at low temperature ([@B51]). This polymer finds applications in the same fields of the other polysaccharides of the gellan family, namely in the oil field, concrete, food products, cosmetics, pharmaceuticals, and medicine (e.g., plastic surgery), referred by [@B60].

Fucose is another rare sugar that is today used in the composition of anticarcinogenic and anti-inflammatory drugs, in the preparation of creams for the acceleration of wound healing and as hydrating and anti-aging additives ([@B38],[@B39]; [@B9]). Fucogel, a fucose containing EPS, has been used extensively in skin care cosmetic formulations ([@B5]; [@B53]). This fact is mainly due to its moisturizing properties and to the scientific evidence of the action of fucogel and fucogel oligosaccharides as skin anti-aging agents, namely for stimulation of fibroblast proliferation and survival ([@B38]). Another recently reported fucose-rich EPS, FucoPol, has demonstrated interesting functional characteristics, such as thickening, emulsion stabilizing, film forming, and flocculating capacities ([@B11]; [@B20]; [@B14]). These properties envisage its application in several areas, namely in emulsion-based cosmetics, drug delivery systems, biodegradable films for packaging, oil drilling fluids, and as biodegradable bioflocculant (e.g., in wastewater treatment).

Hyaluronic acid is abundantly found in mammalian skin where it constitutes a high fraction of the extracellular matrix of the dermis. Its physical and biochemical properties, either in solution or as hydrogel, are attractive for various technologies related to body repair. As such, it is a biomaterial of increasing importance finding applications in cosmetics, pharmaceuticals, and medicine ([@B10]). Either in a stabilized form or in combination with other polymers, it is used in cosmetic surgery as a component of commercial dermal fillers (e.g., Dermalive^®^ and Hylaform^®^). It is reported that injection of such products into the dermis, can reduce facial lines and wrinkles in the long term ([@B7]). HA-based materials have been applied in scaffolds for wound healing, bone and cartilage tissue repair and regeneration, nerve and brain tissue repair, soft tissue repair, and smooth muscle engineering ([@B10]). In addition, this biopolymer has been extensively explored as drug carrier, including target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics ([@B35]).

Conclusion
==========

Only a minority of microbial EPS are today used as commodity products mostly because of their production and purification costs. However, the presence of rare sugars in specific EPS may confer them high added value, to be used in highly specialized applications such as biomedicine, pharmaceuticals, or cosmetics. The physical and chemical properties of the polymers determine their potential applications as thickeners, film producers, emulsion stabilizers, flocculants or materials for nano/microparticles, and scaffolds for tissue engineering among others. In addition to that, their biological activity, potentiated by the occurrence of rare sugars, may offer new market opportunities. EPS microbial production presents the advantage of being simple, robust, reproducible, and easily controllable by growth conditions, such as type and concentration of carbon source, pH, or temperature. However, despite the fact it is possible to produce a polymer with constant characteristics (e.g., composition, purity, and homogeneity), a better understanding of EPS synthesis, in particular EPS with high rare sugars content, is still needed to maximize production and obtain an economical viable process.
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